Primary Myelofibrosis (PMF) Terminated Phase 1 Trials for Zelavespib (DB12638)

Also known as: Primary Myelofibrosis / Primary Myelofibrosis (MF) / Myelofibrosis (PMF) / Myelofibrosis, Primary / PMF / Osteomyelofibrosis / Primary myelofibrosis (disorder) / Myelofibrosis (disorder) / Primary myelofibrosis (morphologic abnormality)

IndicationStatusPhase
DBCOND0044387 (Primary Myelofibrosis (PMF))Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03935555Assess the Safety, Tolerability Oral PU-H71 in Subjects Taking RuxolitinibTreatment
NCT03373877Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of MyelofibrosisTreatment